TIMP2 and breast carcinoma: In another study, TIMP-2 overexpression delayed growth and angiogenesis of mammary carcinoma in vivo in association with downregulation of vascular endothelial growth factor (VEGF) expression, indicating that reduced VEGF expression plays a role in anti-tumorigenic effects of TIMP-2 (118).